Published December 9, 2025 | Version v4

PepQueryMHC: Rapid and Comprehensive Tumor Antigen Prioritization from Immunopeptidomics Data

  • 1. ROR icon Baylor College of Medicine

Description

Data Description

  • LUAD_MHC_I_GTEX.tsv: RNA-seq expression of selected class I tumor antigens from a published lung adenocarcinoma immunopeptidomics study (Abelin, J. G. et al., Gillette, M. A. et al., Lonsdale, J. et al.).
  • LUAD_MHC_II_GTEX.tsv: RNA-seq expression of selected class II tumor antigens from a published lung adenocarcinoma immunopeptidomics study (Abelin, J. G. et al., Gillette, M. A. et al., Lonsdale, J. et al.).
  • MSK_LUAD_Primary_seurat_object.rds: Seurat object containing the single-cell RNA-seq dataset of eight primary lung adenocarcinoma samples (processed) (Laughney, A. M. et al.).
  • PepQueryMHC_top10p_result.tsv: Top 10% most abundant peptides expressed in the eight primary lung adenocarcinoma single-cell RNA-seq samples (Laughney, A. M. et al.).
  • PepQueryMHC.v1.0.5.jar and source code

Files

meta.zip

Files (2.3 GB)

Name Size
md5:d0f7dc8be47bf307902549d40359313d
2.2 GB Preview Download
md5:576206d028a0bd1952a53e2019dce636
150.3 kB Preview Download
md5:d9fe647d5bacc9a23c1e30c2fef150ab
8.7 MB Download

Additional details

Funding

National Institutes of Health
U24 CA271076
Cancer Prevention and Research Institute of Texas
RP240137

Dates

Updated
2025-07-07
Monocyte to macrophage
Updated
2025-10-21
Add the PepQueryMHC executable file
Updated
2025-10-24
Add the source code
Accepted
2025-12-09
Change the license

References

  • Abelin, J. G. et al. Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues. Nat Commun 14, 1851 (2023).
  • Gillette, M. A. et al. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell 182, 200-225.e35 (2020).
  • Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580–585 (2013).
  • Laughney, A. M. et al. Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nat Med 26, 259–269 (2020).